With the dramatic decline in human immunodeficiency
virus (HIV)-related mortality resulting from advances in
combination antiretroviral therapy (ART) and the
longer life expectancy and aging of HIV-infected
persons, there is growing concern about an increased
burden of certain cancers, particularly infection-related
cancers such as anal cancer